-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Omada Health, Lowers Price Target to $24

Benzinga·10/28/2026 15:50:02
Diffusion vocale
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $27 to $24.